XGR-101

N/A

Report date: 2025/01/09 11:34:51

Base Information

Drug NameXGR-101
Drug Alias NameXGR-101
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionMethyl-CpG-binding protein 2 stimulants
TargetsMethyl-CpG-binding protein 2
Therapy Area/IndicationsGenetic Diseases, X-LinkedRett Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlcyone Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlcyone Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsGenetic Diseases, X-LinkedRett Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A